ImmunityBio (IBRX) market cap

Market cap today
$6.66B

ImmunityBio (IBRX) has a market cap of $6.66B. At the end of fiscal 2025 (December 31, 2025) its market cap was $1.82B. That is 1.6% higher than the $1.79B of fiscal 2024. Today's figure is 265.6% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 10:35 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$6.66B
Market cap, fiscal 2025
$1.82B
Change on fiscal 2024
+1.6%
Growth, 5 years
−18.4% a year
Highest on record
$5.03Bfiscal 2020
Lowest on record
$1.39Bfiscal 2019
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

ImmunityBio market cap, in more detail

Over the five fiscal years to 2025 the market cap shrank at a compound 18.4% a year. Across the 7 fiscal year-ends on record (2019–2025), the highest was $5.03B in fiscal 2020 and the lowest $1.39B in fiscal 2019.

History · 7 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

ImmunityBio market cap, year by year

ImmunityBio (IBRX) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$6.66B—$6.26—
2025$1.82B 1.6% up$1.98919.86M
2024$1.79B 29.8% down$2.56700.44M
2023$2.55B 25.9% up$5.02508.64M
2022$2.03B 14.3% down$5.07399.90M
2021$2.37B 52.9% down$6.08389.23M
2020$5.03B 262.0% up$13.33377.07M
2019$1.39B—$3.79366.32M
2018——$1.16—
2017——$4.49—
2016——$5.72—
2015——$17.33—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

Market cap at health care companies of similar size

Market cap of ImmunityBio and comparable companies
CompanyMarket cap
ImmunityBio IBRX$6.66B
ABIVAX ABVX$7.19B

Today's market value as the market data feed reports it, each in the currency its shares trade in.

More on IBRX

ImmunityBio, figure by figure

ImmunityBio (IBRX) overview: price, valuation and scorecardAll health care companies by market value

ImmunityBio market cap: questions and answers

What is ImmunityBio's market cap?

ImmunityBio (IBRX) has a market cap of $6.66B. At the end of fiscal 2025 (December 31, 2025) its market cap was $1.82B. That is 1.6% higher than the $1.79B of fiscal 2024.

What is the growth rate of ImmunityBio's market cap?

Over the five fiscal years to 2025 the market cap shrank at a compound 18.4% a year.

What are the highest and lowest market cap figures on record for ImmunityBio?

Across the 7 fiscal year-ends on record (2019–2025), the highest was $5.03B in fiscal 2020 and the lowest $1.39B in fiscal 2019.

How is ImmunityBio's market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote. For ImmunityBio it is on record here for 7 fiscal years, 2019 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “ImmunityBio (IBRX) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/IBRX/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.